Wilson Sonsini Goodrich & Rosati advised Capsigen Inc. on the deal. Biogen Inc. and Capsigen Inc. announced they have entered into a strategic research collaboration to...
Capsigen’s Research Collaboration with Biogen
Prometheus Biosciences’ $190 Million IPO
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk advised the representatives of the underwriters. Prometheus Biosciences,...